POST-CORONAVIRUS DISEASE 2019 DE QUERVAIN’S THYROIDITIS – A CASE REPORT AND LITERATURE REVIEW
De Quervain’s thyroiditis, also known as subacute thyroiditis (SAT), is a self-limiting inflammatory thyroid disease typically occurring a few weeks after a respiratory viral infection. A 29-year-old female with no comorbidities presented with persistent fever, neck pain, and swelling of 10 days duration. She also had tremors, fatigue, and palpitation. A careful enquiry revealed that she had been diagnosed with coronavirus disease 2019 (COVID-19) infection 6 weeks ago and had recovered uneventfully with conservative management. Her laboratories showed leukocytosis, elevated erythrocyte sedimentation rate, and C-reactive protein. Thyroid function tests (TFTs) yielded low thyroid-stimulating hormone, and high T3 and free T4. Ultrasonography neck was suggestive of thyroiditis. Thyroid scintigraphy demonstrated very low technetium uptake which confirmed SAT. Her symptoms ameliorated with nonsteroidal anti-inflammatory drug and beta-blockers and her TFTs improved during follow-up. We report this as emerging sequelae of COVID-19 infection. A persistent fever and neck pain following recent COVID-19 infection should alert clinician toward the possibility of de Quervain’s thyroiditis following severe acute respiratory syndrome coronavirus 2.
2. Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab 2020;105:dgaa537.
3. Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: An endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) 2020;20:219-21.
4. Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: A case report and review of literature. Eur Thyroid J 2020;9:325-9.
5. Chong WH, Shkolnik B, Saha B, Beegle S. Subacute thyroiditis in the setting of Coronavirus disease 2019. Am J Med Sci 2020. Doi: 10.1016/j.amjms.2020.09.011.
6. Desailloud R, Hober D. Viruses and thyroiditis: An update. Virol J 2009;6:5.
7. Engkakul P, Mahachoklertwattana P, Poomthavorn P. Eponym: De quervain thyroiditis. Eur J Pediatr 2011;170:427-31.
8. Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted county, minnesota, study. J Clin Endocrinol Metab 2003;88:2100-5.
9. Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician 2006;73:1769-76.
10. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: An update. Rev Endocr Metab Disord 2020;1-13. Doi: 10.1007/s11154-020-09615-z.
11. Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted county, minnesota, study. J Clin Endocrinol Metab 2003;88:2100-5.
12. Slatosky J, Shipton B, Wahba H. Thyroiditis: Differential diagnosis and management. Am Fam Physician 2000;61:1047-52, 1054.
13. Volpé R. The management of subacute (DeQuervain’s) thyroiditis. Thyroid 1993;3:253-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.